AFT Pharmaceuticals Limited (AFT.NZ)
NZD 2.78
(-1.42%)
NZD 2.78
(-1.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 64.03 Million NZD | 16.35% |
| 2023 | 55.03 Million NZD | 32.27% |
| 2022 | 41.61 Million NZD | 4.65% |
| 2021 | 39.76 Million NZD | 4.42% |
| 2020 | 38.07 Million NZD | 3.9% |
| 2019 | 36.64 Million NZD | -19.29% |
| 2018 | 45.41 Million NZD | 4.71% |
| 2017 | 43.36 Million NZD | 29.57% |
| 2016 | 33.47 Million NZD | 3.29% |
| 2015 | 32.4 Million NZD | 57.59% |
| 2014 | 20.56 Million NZD | 22.98% |
| 2013 | 16.72 Million NZD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 16.09 Million NZD | -42.72% |
| 2024 Q2 | 32.77 Million NZD | 103.65% |
| 2024 Q4 | 15.67 Million NZD | 2.96% |
| 2024 Q3 | 15.22 Million NZD | -53.54% |
| 2024 FY | 64.56 Million NZD | 17.31% |
| 2023 Q3 | 14.58 Million NZD | -42.19% |
| 2023 Q2 | 25.22 Million NZD | 100.47% |
| 2023 FY | 55.03 Million NZD | 32.27% |
| 2023 Q4 | 28.09 Million NZD | 92.67% |
| 2023 Q1 | 12.58 Million NZD | -37.94% |
| 2022 Q1 | 10.51 Million NZD | -48.74% |
| 2022 FY | 41.61 Million NZD | 4.65% |
| 2022 Q4 | 20.27 Million NZD | 106.65% |
| 2022 Q3 | 9.81 Million NZD | -54.02% |
| 2022 Q2 | 21.33 Million NZD | 102.85% |
| 2021 Q2 | 18.14 Million NZD | 109.58% |
| 2021 Q3 | 10.05 Million NZD | -44.58% |
| 2021 Q4 | 20.51 Million NZD | 104.11% |
| 2021 FY | 39.76 Million NZD | 4.42% |
| 2021 Q1 | 8.65 Million NZD | -54.51% |
| 2020 Q1 | 4.01 Million NZD | -54.63% |
| 2020 Q2 | 17.17 Million NZD | 327.88% |
| 2020 Q4 | 19.02 Million NZD | 86.3% |
| 2020 Q3 | 10.21 Million NZD | -40.52% |
| 2020 FY | 38.07 Million NZD | 3.9% |
| 2019 Q1 | 9.97 Million NZD | -20.86% |
| 2019 FY | 36.64 Million NZD | -19.29% |
| 2019 Q4 | 8.84 Million NZD | 0.0% |
| 2019 Q3 | 8.84 Million NZD | -11.32% |
| 2019 Q2 | 9.97 Million NZD | 0.0% |
| 2018 FY | 45.41 Million NZD | 4.71% |
| 2018 Q2 | 9.69 Million NZD | 0.0% |
| 2018 Q3 | 12.6 Million NZD | 30.04% |
| 2018 Q4 | 12.6 Million NZD | 0.0% |
| 2018 Q1 | 9.69 Million NZD | -7.87% |
| 2017 Q1 | 10.22 Million NZD | -72.68% |
| 2017 Q3 | 10.52 Million NZD | 2.89% |
| 2017 FY | 43.36 Million NZD | 29.57% |
| 2017 Q4 | 10.52 Million NZD | 0.0% |
| 2017 Q2 | 10.22 Million NZD | 0.0% |
| 2016 Q2 | 7.02 Million NZD | 0.0% |
| 2016 FY | 33.47 Million NZD | 3.29% |
| 2016 Q4 | 37.42 Million NZD | 279.85% |
| 2016 Q3 | 9.85 Million NZD | 40.33% |
| 2016 Q1 | 7.02 Million NZD | -26.66% |
| 2015 Q4 | 9.57 Million NZD | 0.0% |
| 2015 Q2 | 6.63 Million NZD | 0.0% |
| 2015 FY | 32.4 Million NZD | 57.59% |
| 2015 Q3 | 9.57 Million NZD | 44.34% |
| 2015 Q1 | 6.63 Million NZD | 0.0% |
| 2014 FY | 20.56 Million NZD | 22.98% |
| 2013 FY | 16.72 Million NZD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Greenfern Industries Limited | 1.71 Million NZD | -3628.394% |
| Rua Bioscience Limited | 2.41 Million NZD | -2546.539% |